Long-term survival outcomes of neoadjuvant chemotherapy in stage II-III HR+/HER2- breast cancer.

Sci Rep · 2025 · PMC12361398 · PMID 40825970

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In N3 stage patients, BCSS showed a statistically significant difference, while OS did not reach statistical significance, reflecting the value of NACT in local control for advanced disease.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.